• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ELEKTA MOSAIQ

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ELEKTA MOSAIQ Back to Search Results
Model Number VERSION 2.41.01JO
Device Problem Retraction Problem (1536)
Patient Problem No Information (3190)
Event Date 02/12/2015
Event Type  malfunction  
Event Description
During treatment of right anterior oblique (rao) boost field, radiation therapist noted that multi-leaf collimator (mlc) appeared retracted.Therapist stopped treatment, notified medical physicist who determined that mlc menu for this field had been changed which caused the mlc's to fully retract in the y-axis.Menu was reset and field was imaged to verify mlc positions.Attending physician notified and reviewed image.He concluded mlc's were now in correct location and ordered delivery of remaining mus.Support services for mosaiq was contacted to confirm when mlc settings were altered.Mosaiq support determined settings were changed after initial verification portal images were acquired.Mosaiq support determined settings were after the initial verification portal images were acquired but before the first fraction of the boost treatment was delivered.Thus, the mlcs were incorrectly retracted on this one beam for about 3.69 fractions.The treatment fields for all the other pts currently under treatment were examined to ensure there was no similar change in mlc settings.The physician, physicist, and dosimetrist recreated the actual treatment in pinnacle (treatment planning system) to determine the effect of mlc retraction on the treatment plan.It was concluded that there was no radiation overdose that would cause impairment to normal tissue function.However, it was noted that the pt's pacemaker (boston scientific) had received 400-450 cgy.A boston scientific representative was called to consult about the dose to the pacemaker.The representative stated that the amount of dose the pacemaker received was significant and the pacemaker needed to be interrogated to determine if damage had occurred.Fortunately, the pt was not pacemaker dependent.The following day ((b)(6) 2015) the boston scientific representative interrogated the pt's pacemaker and concluded that it was working properly.The representative informed the physician.Dates of use: from (b)(6) 2015.Diagnosis or reason for use: squamous cell carcinoma/left lung.Event abated after use stopped or dose reduced: yes.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MOSAIQ
Type of Device
MOSAIQ
Manufacturer (Section D)
ELEKTA
MDR Report Key4664194
MDR Text Key5605413
Report NumberMW5041854
Device Sequence Number1
Product Code IYE
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Nurse
Type of Report Initial
Report Date 03/26/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/01/2015
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Model NumberVERSION 2.41.01JO
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer07/01/2015
Is the Reporter a Health Professional? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
(B)(6) 2015; ELEKTA INFINITY (LINAC) LINEAR ACCELERATOR -
Patient Age79 YR
Patient Weight109
-
-